ESR1 and cancer: Despite having clinical benefits, many studies have demonstrated the reoccurrence of cancer and the development of resistance to these Selective estrogen receptor modulators (SERMs) and Selective estrogen receptor degraders (SERDs) drugs, along with various side effects.